Swiss biotech company Kuros grabs funding
Swiss biotech company Kuros Biosurgery AG has raised CHF15M (approximately over $15.35 million) in funding. LifeCare Partners and LSP Life Sciences Partners led the round with participation from other investors that included Omega Funds, VI Partners (via Venture Incubator) and The Swiss Helvetia Fund Inc. In addition to the funding, Dr. Gerhard Ries, managing partner of LifeCare Partners, Dr. Jörg Neermann, a partner at LSP and Dominik Ellenrieder have been added to the Kuros board.
18 August 2015•4 mins read
